SCHEMBL45416

SCHEMBL45416

COC(OC)C(Cc1ccccc1)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.46
SLC6A2 P23975 4/20 0.46
SLC6A3 Q01959 3/20 0.46
SLC6A4 P31645 2/20 0.46
ADRA2B P18089 2/20 0.46
ADRA2C P18825 2/20 0.46
HTR2A P28223 2/20 0.46
ADRA1A P35348 2/20 0.46
KCNH2 Q12809 2/20 0.46
OPRK1 P41145 1/20 0.46
ALDH1A1 P00352 3/20 0.42
TSHR P16473 3/20 0.42
HPGD P15428 1/20 0.40
LAP3 P28838 1/20 0.40
TAAR1 Q96RJ0 4/20 0.39
MAOA P21397 1/20 0.39
AOC3 Q16853 1/20 0.39
CYP2A6 P11509 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44025 0.87 TSHR (0.41) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL15070157 0.86 SIGMAR1 (0.47) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL44573 0.82 SMN1; SMN2 (0.36) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL44989 0.80 SIGMAR1 (0.41) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL3331448 0.79 SIGMAR1 (0.44) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL44484 0.79 CSNK1E (0.41) SIGMAR1KCNH2
SCHEMBL40135 0.79 TSHR (0.34) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL44789 0.79 TSHR (0.34) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL9328423 0.78 SIGMAR1 (0.50) SIGMAR1SLC6A2SLC6A3SLC6A4ADRA2B
SCHEMBL40060 0.77 KDM4E (0.43) ALDH1A1KDM4EMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079824-B2 Method for the synthesis of an amino acetal NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-07-14 US disclosed
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-06-27 US disclosed
WO-2012005693-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed
WO-2012005693-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL AOX1, DAO, ALDH7A1 SIGMAR1 1259/4885SLC6A2 3038/4885SLC6A3 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.